Attention Training for COVID-19 Related Distress

NCT06267313 | Terminated

• 1 other identifier: 2023-078-PAU
• Study Type: interventional
• Target: 6
• Locations: 1 country
• Sites: 1

Brief Summary

The study aims to test whether attention training (attention bias modification or attention control training) reduces distress or COVID-19 related anxiety compared to a neutral condition.

Conditions

Anxiety

Outcome Measures

Primary Outcomes (4)

• COVID-19 Anxiety Syndrome Scale

  The measure is scored using a 5-point time anchored scale (0 = Not at all to 4 = Nearly every day over the last 2 weeks) and scores range between 0 and 20, with higher scores reflecting worse outcome.

  0 days

• COVID-19 Anxiety Syndrome Scale

  The measure is scored using a 5-point time anchored scale (0 = Not at all to 4 = Nearly every day over the last 2 weeks) and scores range between 0 and 20, with higher scores reflecting worse outcome.

  21 days

• COVID-19 Anxiety Syndrome Scale

  The measure is scored using a 5-point time anchored scale (0 = Not at all to 4 = Nearly every day over the last 2 weeks) and scores range between 0 and 20, with higher scores reflecting worse outcome.

  49 days

• COVID-19 Anxiety Syndrome Scale

  The measure is scored using a 5-point time anchored scale (0 = Not at all to 4 = Nearly every day over the last 2 weeks) and scores range between 0 and 20, with higher scores reflecting worse outcome.

  105 days

Study Arms (3)

Attention Bias Modification

EXPERIMENTAL

Behavioral: Attention Bias Modification

Attention Control Training

ACTIVE COMPARATOR

Behavioral: Attention Control Training

Neutral Training

PLACEBO COMPARATOR

Behavioral: Neutral training

Interventions

Attention Bias Modification BEHAVIORAL

Training attention away from threat

Attention Bias Modification

Attention Control Training BEHAVIORAL

Training attention control

Attention Control Training

Neutral training BEHAVIORAL

Attention training with Neutral stimuli

Neutral Training

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• COVID-19 Anxiety Syndrome Scale \> 7 and/or COVID-19 related loss

You may not qualify if:

• Does not speak English Fluently

Sponsors & Collaborators

• Palo Alto University: lead

Study Sites (1)

Palo Alto University

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: February 17, 2024
• First Posted: February 20, 2024
• Study Start: February 19, 2024
• Primary Completion: November 9, 2024
• Study Completion: November 9, 2024
• Last Updated: November 12, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will share
• Shared Documents: ANALYTIC CODE
• Time Frame: Analytic code will be shared with accompanying manuscript

Locations

US (1)